Privacy, personalization, and other digital challenges for healthcare marketers.
Healthcare marketers face a landscape defined by two key challenges: privacy and personalization. These two forces shape the way we engage with patients and consumers, pushing us to adapt our strategies and rethink how we use data in a highly regulated space. If you work in healthcare marketing, there’s no doubt your work life has been heavily impacted by evolving HIPAA regulations over the last few years, specifically around the definition of Protected Health Information (PHI) and what that means for our marketing efforts. Likely, you’re searching for ways to deliver personalized, data-driven campaigns without violating HIPAA. So, what do these shifts mean for healthcare marketers, and what can we expect going forward? Let’s dive into the trends that are driving change and how marketers are adapting to meet the demands of privacy and personalization.
For those not deeply involved in healthcare marketing, let’s take a step back and explain the situation. Digital advertising relies heavily on data. Marketers gather information about customer behavior, demographics, and interests through platforms like social media, search engines, and websites. This data helps us serve the right ads to the right people at the right time—whether it’s based on online behavior, offline activities like shopping patterns, or even loyalty program participation.
However, when it comes to healthcare marketing, the stakes are higher. HIPAA (the Health Insurance Portability and Accountability Act) has placed strict guidelines around how patient data is collected, used, and shared. These regulations are becoming even more stringent, forcing marketers to rethink their digital strategies.
What you can know and what you can’t.
While there are many variables and exceptions around the impact of HIPAA regulations like these, here are a few examples of what regulations meant for digital advertisers in the healthcare space:
Limited use of tracking technologies: Tracking pixels, cookies, and other data collection methods used to monitor user behavior online are under scrutiny. The challenge here is to avoid collecting PHI (patient health information) through these methods.
Data de-identification: When using patient data for marketing, it must be anonymized so that it cannot be traced back to an individual. This ensures compliance with HIPAA.
Third-party vendor compliance: If you work with external vendors, such as Google or Meta, they must sign a Business Associate Agreement (BAA) to ensure they comply with HIPAA regulations.
What does this mean for marketers? First, you can no longer target ads based on sensitive health information, such as specific medical conditions. For example, if a patient visits your page about diabetes, you can’t target them with additional diabetes-related ads based on their browsing history. You also can’t use tools like Google Analytics without anonymizing the data first, as Google isn’t signing BAAs. This creates significant gaps in tracking and performance measurement, making it harder to optimize and assess the ROI of digital marketing campaigns.